Results 111 to 120 of about 23,180 (193)

Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B

open access: yesThe Turkish Journal of Pediatrics, 2002
Visceral leishmaniasis is a worldwide, disseminated intracellular protozoal infection that usually manifests by fever, hepatosplenomegaly, anemia, thrombocytopenia, leukopenia and hypergammaglobulinemia. Although anemia is a usual finding, Coombs'
Embiya Dilber   +2 more
doaj  

Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children

open access: yesThe Turkish Journal of Pediatrics, 2013
The aim of this study was to investigate the efficacy of a 21-day schedule of liposomal amphotericin B compared to pentavalent antimony salts in the treatment of patients during a first episode of visceral leishmaniasis. In this study, 17 cases of
Hurşit Apa   +5 more
doaj  

Liposomal amphotericin B in the treatment of pediatric gastrointestinal basidiobolomycosis. [PDF]

open access: yesJ Med Case Rep
Forooghi M   +5 more
europepmc   +1 more source

Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis? [PDF]

open access: yesExpert Rev Anti Infect Ther
Schwartz EL, Bahr NC, Rajasingham R.
europepmc   +1 more source

Successful desensitization to liposomal amphotericin B for the treatment of disseminated cryptococcosis in pregnancy: a case report. [PDF]

open access: yesASM Case Rep
Ajao SO   +7 more
europepmc   +1 more source

Miltefosine in visceral leishmaniasis.

open access: yes, 2003
Bryceson, Anthony DM   +4 more
core   +1 more source

Liposomal amphotericin B prophylaxis in paediatrics: a systematic review. [PDF]

open access: yesJ Antimicrob Chemother
Thorley EV   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy